FDA grants traditional approval for LEQEMBI® (lecanemab-irmb) for the treatment of Alzheimer's disease (3)
STOCKHOLM, July 7, 2023 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai...
Source: europapress.es
Page 14 - Access Pathway News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Access Pathway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Access Pathway Today - Breaking & Trending Today
FDA grants traditional approval for LEQEMBI® (lecanemab-irmb) for the treatment of Alzheimer's disease (2)
STOCKHOLM, July 7, 2023 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai...
Source: europapress.es
FDA grants traditional approval for LEQEMBI® (lecanemab-irmb) for the treatment of Alzheimer's disease
/PRNewswire/ -- BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the U.S. Food and Drug Administration, FDA, has approved...
Source: prnewswire.com
American Medical Association Releases Language of First New Current Procedural Terminology Code for Psychedelic Therapies
LONDON, July 06, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a biotechnology company dedicated to accelerating patient access to…
Source: sina.com.hk
COMPASS Pathways : Secures Term Loan Facility for Up to $50 Million from Hercules Capital
COMPASS Pathways Secures Term Loan Facility for Up to $50 Million from Hercules Capital London, UK - July 5, 2023 COMPASS...
Source: marketscreener.com